Urinary incontinence future or investigational therapies

Urinary incontinence Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Urinary incontinence from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-Ray Findings
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Urinary incontinence future or investigational therapies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Urinary incontinence future or investigational therapies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Urinary incontinence future or investigational therapies
CDC on Urinary incontinence future or investigational therapies
Urinary incontinence future or investigational therapies in the news
Blogs on Urinary incontinence future or investigational therapies
Directions to Hospitals Treating Urinary incontinence
Risk calculators and risk factors for Urinary incontinence future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Future or Investigational Therapies

There are also trials taking place in the UK at the moment using Botox. It has been tested with some success under general anaesthetic conditions, and is currently (February 2006) being tried under local anaesthetic. While it originally appears that it may be quite successful for women, it does not appear to be as successful for men. Botox works for around 6-9 months when the treatment has to be redone.